Advertisement
Screener

ABEONA THERAPEUTICS INC. (ABEO) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

ABEONA THERAPEUTICS INC. Cash Flow Breakdown

Cash flow breakdown shows where ABEONA THERAPEUTICS INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $76.33M went out.
  • Fiscal year ended 2025-12-31: from investing, $105.03M came in.
  • Fiscal year ended 2025-12-31: from financing, $26.04M came in.
  • Fiscal year ended 2025-12-31: change in cash, $54.74M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew debtNew shares soldNot split outChange in cash
2025-12-31-$76.33M$105.03M$17.30M$8.74M*$54.74M
2024-12-31-$56.02M-$39.24M$20.00M$15.47M$68.66M*$8.88M
2023-12-31-$37.01M$208.00K$14.41M$22.65M*$256.00K
2022-12-31-$43.48M-$23.96M$12.84M$30.33M*-$24.27M
2021-12-31-$65.67M$66.06M$8.05M$16.81M*$25.26M
2020-12-31-$35.02M-$83.71M$177.00K$1.76M*-$116.80M
2019-12-31-$62.82M$59.98M$16.96M$96.94M*$111.06M
2018-12-31-$39.11M-$85.09M$2.24M$3.23M*-$118.72M
2017-12-31-$22.66M-$860.00K$344.00K$92.06M*$68.89M
2016-12-31-$13.01M-$519.00K$350.00K$42.19M*$29.00M
2015-12-31-$10.42M$3.39M$7.00M$28.65M*$28.62M
2014-12-31-$1.61M$0.00$0.00$12.71M*$11.10M
2013-12-31$1.00K-$2.00K$0.00$28.00K
2012-12-31-$3.96M-$13.00K$0.00$1.90M*-$2.06M
2011-12-31-$7.61M-$40.00K$5.83M-$2.75M*-$4.57M
2010-12-31-$6.86M-$7.00K$13.10M$6.43M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2026-06-30-$17.50M*$15.69M*-$3.33M*
2026-03-31-$19.80M$4.96M-$2.22M-$17.06M
2025-12-31-$17.95M*$9.55M*$0.00*$3.61M*
2025-09-30-$21.19M*-$64.63M*$0.00*$5.16M*
2025-06-30-$18.78M*$155.89M*$10.50M*
2025-03-31-$18.40M$4.21M$6.80M-$7.42M
2024-12-31-$16.56M*$18.88M*$0.00*$5.51M*
2024-09-30-$12.23M*-$6.17M*$0.00*$0.00*
2024-06-30-$12.68M*-$44.13M*$0.00*$3.54M*$70.14M*
2024-03-31-$14.54M-$7.82M$20.00M$6.42M-$977.00K*$3.08M
2023-12-31-$9.23M*$11.53M*$7.79M*
2023-09-30-$5.75M*-$18.74M*$0.00*$22.98M*
2023-06-30-$10.28M*$5.21M*$6.62M*
2023-03-31-$11.74M$2.21M-$9.54M
2022-12-31-$13.99M*-$25.29M*$8.65M*$34.12M*
2022-09-30-$6.79M*$1.65M*$4.19M*
2022-06-30-$9.01M*-$1.40M*
2022-03-31-$13.69M$1.07M-$12.61M
2021-12-31-$30.26M*$8.00M*$352.00K*$15.98M*
2021-09-30-$10.33M*$26.76M*$33.00K*
2021-06-30-$11.49M*$21.92M*$2.46M*
2021-03-31-$13.59M$9.38M$5.21M$667.00K*$1.67M
2020-12-31-$1.61M*$5.78M*$2.00K*
2020-09-30-$10.70M*$4.58M*$0.00*
2020-06-30-$9.47M*-$18.21M*
2020-03-31-$13.23M-$75.87M-$89.10M
2019-12-31-$14.25M*-$946.00K*-$1.00K*$96.53M*
2019-09-30-$18.25M*$19.23M*$4.34M*
2019-06-30-$15.24M*$18.92M*$385.00K*$12.62M*
2019-03-31-$15.08M$22.77M$28.00K$7.72M
2018-12-31-$16.97M*$2.12M*-$1.00K*
2018-09-30-$9.04M*-$10.43M*$79.00K*$3.00M*
2018-06-30-$9.02M*-$73.27M*$481.00K*
2018-03-31-$4.08M-$3.50M$1.69M-$5.75M
2017-12-31-$5.05M*-$704.00K*$251.00K*$87.01M*$81.23M*
2017-09-30-$6.77M*-$72.00K*$8.00K*$5.05M*-$1.78M*
2017-06-30-$4.98M*-$10.00K*$85.00K*-$4.91M*
2017-03-31-$5.86M-$74.00K$0.00-$5.93M
2016-12-31-$3.39M*-$18.00K*$350.00K*$41.02M*$37.96M*
2016-09-30-$3.99M*-$148.00K*$0.00*$1.02M*-$3.12M*
2016-06-30-$3.12M*-$126.00K*$0.00*-$3.09M*
2016-03-31-$2.52M-$227.00K$0.00-$2.74M
2015-12-31-$2.88M*-$267.00K*$0.00*-$3.14M*
2015-09-30-$2.51M*-$27.00K*$0.00*$15.41M*$12.87M*
2015-06-30-$1.87M*$3.69M*$20.64M*$22.46M*
2015-03-31-$3.16M-$9.00K-$3.57M
2014-12-31-$1.10M*$0.00*$0.00*$12.46M*$11.36M*
2014-09-30-$140.00K*$0.00*$0.00*$110.00K*
2014-06-30-$244.00K*$0.00*-$244.00K*
2014-03-31-$125.00K$0.00-$125.00K
2013-12-31-$474.00K*-$1.00K*$0.00*-$475.00K*
2013-09-30-$916.00K*-$1.00K*$18.00K*-$899.00K*
2013-06-30$1.74M*$0.00*$1.75M*
2013-03-31-$346.00K$0.00-$346.00K
2012-12-31-$1.62M*$2.00K*$0.00*$1.90M*$290.00K*
2012-09-30-$482.00K*$0.00*$0.00*-$482.00K*
2012-06-30-$775.00K*-$2.00K*-$777.00K*
2012-03-31-$1.08M-$13.00K-$1.09M
2011-12-31-$1.96M*$0.00*$5.83M*-$2.75M*$1.11M*
2011-09-30-$3.00M*-$1.00K*$0.00*-$3.00M*
2011-06-30-$1.81M*-$17.00K*-$1.83M*
2011-03-31-$837.00K-$22.00K-$859.00K
2010-12-31-$1.72M*$0.00*$7.25M*$5.54M*
2010-09-30-$1.31M*$1.00K*$0.00*-$1.26M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
Evommune, Inc. (EVMN)United States$0.320B-5.10
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40